Akari Therapeutics, Plc Total Assets
Akari Therapeutics, Plc (AKTX) had Total Assets of $38.62 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-13
- 2026-06-30: Assets $38.62M.
- 2026-03-31: Assets $33.89M.
- 2025-12-31: Assets $47.89M.
- 2025-09-30: Assets $45.38M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $38.62M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $33.89M 10-Q · filed 2026-05-19 | |
| 2025-12-31 | $47.89M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $45.38M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $50.91M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $50.96M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $50.56M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.73M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $1.43M 8-K · filed 2024-09-06 | $5.08M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $2.77M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $4.36M 10-K · filed 2025-04-15 | |
| 2023-06-30 | $8.01M 6-K · filed 2023-09-29 | |
| 2022-12-31 | $7.53M 8-K · filed 2024-09-06 | $13.83M 20-F · filed 2023-05-01 |
| 2022-06-30 | $11.37M 6-K · filed 2022-09-27 | |
| 2021-12-31 | $11.65M 20-F · filed 2023-05-01 | |
| 2021-06-30 | $4.83M 6-K · filed 2021-09-22 | |
| 2020-12-31 | $14.60M 20-F · filed 2022-05-16 | |
| 2020-09-30 | $13.69M 20-F · filed 2021-04-21 | |
| 2020-06-30 | $14.45M 20-F · filed 2021-04-21 | |
| 2020-03-31 | $9.68M 20-F · filed 2021-04-21 | |
| 2019-12-31 | $6.48M 20-F · filed 2021-04-21 | $6.80M 20-F · filed 2020-03-31 |
| 2019-09-30 | $10.27M 20-F · filed 2021-04-21 | |
| 2019-06-30 | $4.61M 20-F · filed 2021-04-21 | $5.15M 6-K · filed 2019-08-29 |
| 2019-03-31 | $8.23M 20-F · filed 2021-04-21 | |
| 2018-12-31 | $8.03M 20-F · filed 2020-03-31 | |
| 2018-06-30 | $17.12M 6-K · filed 2018-09-27 | |
| 2017-12-31 | $29.05M 20-F · filed 2019-04-23 | |
| 2017-06-30 | $32.05M 6-K · filed 2017-08-10 | |
| 2016-12-31 | $45.87M 20-F · filed 2018-07-18 | |
| 2016-06-30 | $57.63M 6-K · filed 2017-04-14 | |
| 2016-03-31 | $62.96M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $69.89M 6-K · filed 2017-04-14 | |
| 2015-09-30 | $79.17M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $2.96M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $4.32M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $3.39M 10-K · filed 2016-03-23 | $6.48M 10-K · filed 2015-02-11 |
| 2013-12-31 | $7.83M 10-K · filed 2015-02-11 | |
| 2012-12-31 | $1.12M 20-F · filed 2014-03-24 | |
| 2011-12-31 | $27.00K 20-F/A · filed 2013-04-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |